CDE Catalog

***Please contact the NINDS CDE Team (NINDSCDE@emmes.com) if you encounter any search difficulties.***

The CDE Catalog is a directory of the available NINDS CDEs. Users can search the Catalog to isolate a subset of the CDEs (e.g., all stroke-specific CDEs, etc.), and to view and download details about the CDEs.

Select any filter below to search the CDE Catalog.

For best results, clear form between searches. In addition, when specifying NeuroRehab, Sport-Related Concussion (SRC) or Traumatic Brain Injury (TBI) as the Disease, please select a Subdisease as well.

NeuroRehab Comprehensive includes all NeuroRehab CDE recommendations. NeuroRehab General includes all NeuroRehab CDE recommendations that are not disease specific. All other NeuroRehab Subdiseases include recommendations specific to existing NINDS CDE project disorders.

Choose your Time Frame for your SRC study (Acute (time of injury until 72 hours), Subacute (after 72 hours to 3 months), and Persistent/Chronic (3 months and greater post-concussion) or Comprehensive if your study falls across the study time frames.

Choose your type of TBI study (Acute Hospitalized, Concussion/Mild TBI, Moderate/Severe TBI: Rehabilitation, or Epidemiology) or Comprehensive if your study falls outside of the study types or incorporates aspects of more than one type of study.

Search Form

Displaying 726 - 750 of 1834
Operations
Selected 25 rows in this page.  
The search results below can be downloaded by clicking the checkboxes on the far left side of the table. Select the header checkbox to select all CDEs listed on the first page. Then choose CDE Detailed Report from the Choose an operation dropdown menu.
CDE ID CDE Name Definition Classification CRF Name Copyrighted or trademarked Disease Name Subdisease Name
C59839 Left eye vision status

Status of the participant's vision using the left eye

Supplemental Vestibular Function in Mitochondrial Disease Mitochondrial Disease Mitochondrial Disease
C02411 Laterality type

Laterality type relative to the anatomic site of the body examined or affected

Supplemental DXA Mitochondrial Disease Mitochondrial Disease
C02411 Laterality type

Laterality type relative to the anatomic site of the body examined or affected

Exploratory Vestibular Function in Mitochondrial Disease Mitochondrial Disease Mitochondrial Disease
C02411 Laterality type

Laterality type relative to the anatomic site of the body examined or affected

Supplemental Cardiac Magnetic Resonance Imaging (MRI) Mitochondrial Disease Mitochondrial Disease
C02411 Laterality type

Laterality type relative to the anatomic site of the body examined or affected

Core Imaging - Mitochondrial Disease Mitochondrial Disease Mitochondrial Disease
C02411 Laterality type

Laterality type relative to the anatomic site of the body examined or affected

Core Head Computed Tomography (CT) Mitochondrial Disease Mitochondrial Disease
C56163 Last calibration date time

The date and time of the last time the machine was calibrated

Supplemental-Highly Recommended Staged Exercise Tolerance Test Mitochondrial Disease Mitochondrial Disease
C59734 Lactose intolerant indicator

Indicator of whether that the participant is lactose intolerant

Supplemental Bone Health History Mitochondrial Disease Mitochondrial Disease
C19728 Laboratory procedure VLDL cholesterol measurement

Measurement of the amount of very low density lipoprotein (VLDL) cholesterol in the participant's blood

Supplemental Diabetes Labs Mitochondrial Disease Mitochondrial Disease
C19729 Laboratory procedure vitamin D twenty five hydroxy measurement

Measurement of the amount of vitamin D twenty five hydroxy in the participant's blood

Exploratory Diabetes Labs Mitochondrial Disease Mitochondrial Disease
C19725 Laboratory procedure two hour glucose measurement

Measurement of the amount of glucose in the participant's blood 2 hours after a 75-gram glucose drink has been ingested

Supplemental Diabetes Labs Mitochondrial Disease Mitochondrial Disease
C18169 Laboratory procedure triglycerides measurement

Measurement of the amount of triglycerides in the participant's blood

Supplemental Diabetes Labs Mitochondrial Disease Mitochondrial Disease
C18168 Laboratory procedure total cholesterol measurement

Measurement of the total amount of cholesterol in the participant's blood

Supplemental Diabetes Labs Mitochondrial Disease Mitochondrial Disease
C57974 Laboratory procedure random glucose measurement

Measurement of the amount of glucose in the participant's blood at a random/non-fasting time

Supplemental Diabetes Labs Mitochondrial Disease Mitochondrial Disease
C19730 Laboratory procedure microalbumin urine measurement

Measurement of the amount of microalbumin in the participant's urine

Supplemental Diabetes Labs Mitochondrial Disease Mitochondrial Disease
C18147 Laboratory procedure LDL cholesterol measurement

Measurement of the amount of low density lipoprotein (LDL) cholesterol in the participant's blood

Supplemental Diabetes Labs Mitochondrial Disease Mitochondrial Disease
C18146 Laboratory procedure HDL cholesterol measurement

Measurement of the amount of high density lipoprotein (HDL) cholesterol in the participant's blood

Supplemental Diabetes Labs Mitochondrial Disease Mitochondrial Disease
C19722 Laboratory procedure glycosylated hemoglobin measurement

Measurement of the amount of glycosylated hemoglobin (hemoglobin A1C) in the participant's blood

Supplemental-Highly Recommended Diabetes Labs Mitochondrial Disease Mitochondrial Disease
C19722 Laboratory procedure glycosylated hemoglobin measurement

Measurement of the amount of glycosylated hemoglobin (hemoglobin A1C) in the participant's blood

Exploratory Diabetes-Related Medical History Mitochondrial Disease Mitochondrial Disease
C19726 Laboratory procedure fasting insulin measurement

Measurement of the amount of insulin in the participant's blood when fasting

Supplemental Diabetes Labs Mitochondrial Disease Mitochondrial Disease
C19724 Laboratory procedure fasting glucose measurement

Measurement of the amount of glucose in the participant's blood when fasting

Supplemental-Highly Recommended Diabetes Labs Mitochondrial Disease Mitochondrial Disease
C19727 Laboratory procedure fasting C-peptide measurement

Measurement of the amount of C-peptide in the participant's blood when fasting

Supplemental Diabetes Labs Mitochondrial Disease Mitochondrial Disease
C60249 Laboratory procedure anti-pancreatic autoantibody name

Name of the anti-pancreatic autoantibody measured in the participant's blood

Supplemental-Highly Recommended Diabetes Labs Mitochondrial Disease Mitochondrial Disease
C19723 Laboratory procedure anti-pancreatic autoantibodies value

Value of the amount of anti-pancreatic autoantibodies in the participant's blood

Supplemental-Highly Recommended Diabetes Labs Mitochondrial Disease Mitochondrial Disease
C60355 Lab urine specimen fast prior indicator

Indicator of whether the participant was fasting prior to collection of urine lab specimen

Supplemental Labs of Bone Mineral Metabolism Mitochondrial Disease Mitochondrial Disease
Displaying 726 - 750 of 1834

The NINDS CDE Team does not post proprietary instruments/scales recommended by the CDE Working Groups on this website. This includes, but is not limited to, copyrighted or trademarked instruments/scales. Information about recommended instruments can be found in the Notice of Copyright (NOC) documents under ‘CRF Module/Guideline’ on each disorder’s data standards page. For any questions regarding these instruments/scales please contact the corresponding owner/author. The NINDS CDE Team is not responsible for the availability or content of these external sites, nor does the NINDS CDE Team endorse, warrant or guarantee the products, services or information described or offered at these other internet sites.